Log in to save to my catalogue

Prevalence and trend of central nervous system–active medication polypharmacy among US commercially...

Prevalence and trend of central nervous system–active medication polypharmacy among US commercially...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_01bd96e13fdf482cbd391cffb99c5c8e

Prevalence and trend of central nervous system–active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional study

About this item

Full title

Prevalence and trend of central nervous system–active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional study

Publisher

England: BioMed Central

Journal title

Alzheimer's research & therapy, 2024-02, Vol.16 (1), p.30-30, Article 30

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Limited data exist on the prevalence and trend of central nervous system (CNS)-active medication polypharmacy among adults with early-onset dementia (EOD) and whether these estimates differ for adults without EOD but with chronic pain, depression, or epilepsy, conditions managed by CNS-active medications.
A multi-year, cross-sectional study usin...

Alternative Titles

Full title

Prevalence and trend of central nervous system–active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional study

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_01bd96e13fdf482cbd391cffb99c5c8e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_01bd96e13fdf482cbd391cffb99c5c8e

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-024-01405-y

How to access this item